| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/12/2009 | WO2009108632A9 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| 11/12/2009 | WO2009103901A3 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas |
| 11/12/2009 | WO2009098595A3 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| 11/12/2009 | WO2009097570A3 Intralymphatic chemotherapy drug carriers |
| 11/12/2009 | WO2009093143A3 Therapeutic vaccines |
| 11/12/2009 | WO2009090495A3 Oil and liquid silicone foamable carriers and formulations |
| 11/12/2009 | WO2009080715A3 Vaccines for malaria |
| 11/12/2009 | WO2009072007A3 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| 11/12/2009 | WO2009069006A3 Foam containing benzoyl peroxide |
| 11/12/2009 | WO2009038779A3 Methods and compositions for inhibiting undesirable cellular proliferation by targeted liposome delivery of active agents |
| 11/12/2009 | WO2009012901A3 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
| 11/12/2009 | WO2009002521A3 Compositions of specific binding agents to hepatocyte growth factor |
| 11/12/2009 | US20090281296 Process for the production of conjugates from polysaccharides and polynucelotides |
| 11/12/2009 | US20090281199 Cosmetic composition and cosmetic |
| 11/12/2009 | US20090281198 Moisturizer |
| 11/12/2009 | US20090281197 Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis |
| 11/12/2009 | US20090281188 treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata or secondary acne with adapalene; sunscreen agents; antiproliferative agents |
| 11/12/2009 | US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 11/12/2009 | US20090281158 Prodrugs of cc-1065 analogs |
| 11/12/2009 | US20090281093 Anti-inflammatory compounds |
| 11/12/2009 | US20090281068 Polylactide compositions and uses thereof |
| 11/12/2009 | US20090280164 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 11/12/2009 | US20090280157 Method of Modifying Materials Surfaces |
| 11/12/2009 | US20090280154 Biodegradable Scaffold with ECM Material |
| 11/12/2009 | US20090280148 Casein nanoparticle |
| 11/12/2009 | US20090280129 High concentration antibody and protein formulations |
| 11/12/2009 | US20090280120 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 11/12/2009 | US20090280066 Methods and compounds for the treatment of mucus hypersecretion |
| 11/12/2009 | CA2724469A1 Tooth movement activating composition |
| 11/12/2009 | CA2723746A1 Complex |
| 11/12/2009 | CA2723558A1 Compositions of gnrh related compounds and processes of preparation |
| 11/12/2009 | CA2723541A1 Compositions of peptides and processes of preparation thereof |
| 11/12/2009 | CA2722474A1 Anti-angiogenic compounds |
| 11/12/2009 | CA2721307A1 Encapsulation of biologically active agents |
| 11/12/2009 | CA2720493A1 High-fluidity and non-caking pulverulent crystalline maltitol composition |
| 11/11/2009 | EP2116561A1 Multibranched polyoxyalkylene derivative |
| 11/11/2009 | EP2116266A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 11/11/2009 | EP2116265A2 Reduced-viscosity concentrated protein formulations |
| 11/11/2009 | EP2116264A1 Preparation for transnasal application |
| 11/11/2009 | EP2116263A1 Reversibly light-switchable drug-conjugates |
| 11/11/2009 | EP2116256A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| 11/11/2009 | EP2116243A1 Gel composition for treating mycosis |
| 11/11/2009 | EP2116241A1 Pharmaceutical composition |
| 11/11/2009 | EP2116237A1 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 11/11/2009 | EP2116234A1 Pharmaceutical composition for external application and adhesive skin patch |
| 11/11/2009 | EP2116233A1 Dual component alginate |
| 11/11/2009 | EP2116228A1 Novel cyclosporin analog microemulsion preconcentrates |
| 11/11/2009 | EP2116227A2 Ophthalmic compositions containing a synergistic combination of two polymers |
| 11/11/2009 | EP2115129A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 11/11/2009 | EP2115011A1 Cytocompatible stable gel compositions as supports for cell growth |
| 11/11/2009 | EP2115008A1 Biodegradable material based on opened starch |
| 11/11/2009 | EP2115001A1 Coupling of antibody polypeptides at the c-terminus |
| 11/11/2009 | EP2114456A2 Stabilization of aqueous compositions of proteins with displacement buffers |
| 11/11/2009 | EP2114454A2 Chemical linkers and cleavable substrates and conjugates thereof |
| 11/11/2009 | EP2114451A2 Anti-il-13 antibody formulations and uses thereof |
| 11/11/2009 | EP2114437A2 Modified corticotropin releasing factor peptides and uses thereof |
| 11/11/2009 | EP2114397A2 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof |
| 11/11/2009 | EP2114384A2 Compositions and methods for enhancing transmucosal delivery |
| 11/11/2009 | EP2114381A1 An oral sustained-release triple layer tablet |
| 11/11/2009 | EP2114380A1 Modified release pharmaceutical composition and a process of making the same |
| 11/11/2009 | EP2114377A2 Controlled release of actives in skin |
| 11/11/2009 | EP2114372A1 Pharmaceutical carrier composition and pharmaceutical composition |
| 11/11/2009 | EP2114370A2 Novel biomaterials for ocular drug delivery and a method for making and using same |
| 11/11/2009 | EP2114369A1 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases |
| 11/11/2009 | EP2114368A1 Pharmaceutical compositions comprising a bisphosphonate compound |
| 11/11/2009 | EP2114157A1 Phosphoramidate alkylator prodrugs for the treatment of cancer |
| 11/11/2009 | EP2114145A2 Phenylalkylcarboxylic acid delivery agents |
| 11/11/2009 | EP2114138A2 Cold storage of modified platelets |
| 11/11/2009 | EP1928508B1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 11/11/2009 | EP1689789B1 Novel cyclodextrin dimers and derivatives thereof, methods for preparing them and their use, in particular, for solubilizing pharmacologically active substances |
| 11/11/2009 | EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 11/11/2009 | EP1482795B1 New immunoeffector compounds |
| 11/11/2009 | EP1430896B1 Nicotine-containing film preparation |
| 11/11/2009 | EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 11/11/2009 | EP1191943B1 Anti-allergic peptides |
| 11/11/2009 | CN101578106A HGF preparation |
| 11/11/2009 | CN101578103A Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 11/11/2009 | CN101574527A Liver-targeting intelligent nano-micelle prodrug system and preparation thereof |
| 11/11/2009 | CN101574526A Mixed vegetable oil used for black plaster production and application thereof |
| 11/11/2009 | CN101574525A Hydroxypropyl-beta-cyclodextrin inclusion compound for lipophilic medicaments, and preparation method thereof |
| 11/11/2009 | CN101574524A Sulfoalkyl ether cyclodextrin inclusion compound for lipophilic medicaments, and preparation method thereof |
| 11/11/2009 | CN101574523A Inclusion compound of water-soluble derivatives of cyclodextrin of volatile oil and preparation method thereof |
| 11/11/2009 | CN101574522A Vagina slowly-releasing administration system |
| 11/11/2009 | CN101574521A Oral combination shielding indisposed taste |
| 11/11/2009 | CN101574518A Hapten-carrier conjugates and uses thereof |
| 11/11/2009 | CN101574514A Product for treating myocardial infarction based on chitosan aquagel and growth factor |
| 11/11/2009 | CN101574507A Nasal administration system for treating headache |
| 11/11/2009 | CN101574504A Medical composition for treating mammary gland diseases and preparation method thereof |
| 11/11/2009 | CN101574441A Composition with function of clearing throat and preparation method thereof |
| 11/11/2009 | CN101574425A Child cough granule and preparation method of same |
| 11/11/2009 | CN101574413A Traditional Chinese medicine preparation for curing rheumatoid arthritis and preparation method thereof |
| 11/11/2009 | CN101574411A Shuang dan orally disintegrating tablet |
| 11/11/2009 | CN101574397A WuRenChun self-emulsifying soft capsule preparation and preparation method |
| 11/11/2009 | CN101574394A Strychnos alkaloid vesicle and preparation method thereof |
| 11/11/2009 | CN101574393A Method for preparing salvia miltiorrhiza colloid injection or infusion |
| 11/11/2009 | CN101574389A Dripping pill for treating pharyngeal and laryngeal diseases and preparation method thereof |
| 11/11/2009 | CN101574380A Flavone acetylsalicylate solid dispersion and preparation method thereof |
| 11/11/2009 | CN101574379A Flavone hippophaes self-emulsifying formulation and preparation method thereof |
| 11/11/2009 | CN101574376A Chinese medicinal cataplasm matrix and preparation method thereof |
| 11/11/2009 | CN101574373A Toad venom alcohol plastid and preparation method thereof |